Rese-Cel CAR T Therapy Secures EMA PRIME Designation

 
• By Neena Brizmohun
  
Inflammatory myopathy written on a board
A CAR T-cell therapy for idiopathic inflammatory myopathy has received EMA PRIME designation (Shutterstock)

More from Review Pathways

More from Europe